We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

58 hedge funds and large institutions have $30.1M invested in Adverum Biotechnologies in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

11.48% less ownership

Funds ownership: 78.54% → 67.06% (-11%)

17% less funds holding

Funds holding: 70 → 58 (-12)

25% less call options, than puts

Call options by funds: $3K | Put options by funds: $4K

38% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 29

50% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 18

57% less capital invested

Capital invested by funds: $69.8M → $30.1M (-$39.7M)

Holders
58
Holders Change
-12
Holders Change %
-17.14%
% of All Funds
0.76%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
9
Reduced
18
Closed
29
Calls
$3K
Puts
$4K
Net Calls
-$1K
Net Calls Change
+$13K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.15M
2
Millennium Management
Millennium Management
New York
+$958K
3
PWA
Principia Wealth Advisory
Texas
+$930K
4
BCM
BML Capital Management
Indiana
+$882K
5
Citadel Advisors
Citadel Advisors
Florida
+$219K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$7.69M
2
BlackRock
BlackRock
New York
-$2.83M
3
State Street
State Street
Massachusetts
-$826K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$745K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$407K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$88.7K -$27.9K -9,956 -19%
Northern Trust
27
Northern Trust
Illinois
$73.9K -$324K -115,981 -77%
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$66K +$85.8K +30,679 New
HF
29
HRT Financial
New York
$65K +$85.7K +30,627 New
XT
30
XTX Topco
Cayman Islands
$64K +$83.2K +29,755 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$57.5K -$537 -192 -0.7%
JG
32
Jain Global
New York
$46.9K +$61K +21,819 New
Squarepoint
33
Squarepoint
New York
$46.6K +$60.6K +21,652 New
YIH
34
Y-Intercept (HK)
Hong Kong
$45.4K +$59.1K +21,122 New
Two Sigma Investments
35
Two Sigma Investments
New York
$40.3K +$52.5K +18,757 New
PAS
36
Point72 Asia (Singapore)
Singapore
$31.4K +$40.8K +14,582 New
UBS Group
37
UBS Group
Switzerland
$30.5K -$121K -43,378 -75%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$23K +$29.9K +10,681 New
American Century Companies
39
American Century Companies
Missouri
$22.9K -$19.5K -6,977 -40%
CAPTRUST Financial Advisors
40
CAPTRUST Financial Advisors
North Carolina
$21.5K -$1.75K -624 -6%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$6K +$604 +216 +8%
Carson Wealth (CWM LLC)
42
Carson Wealth (CWM LLC)
Nebraska
$5K +$1.05K +375 +21%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$5K -$31.2K -11,146 -83%
TRCT
44
Tower Research Capital (TRC)
New York
$4.59K -$741 -265 -11%
CSS
45
Cubist Systematic Strategies
Connecticut
$4.12K +$5.36K +1,916 New
Osaic Holdings
46
Osaic Holdings
Arizona
$3.63K +$4.32K +1,544 +1,065%
Jones Financial Companies
47
Jones Financial Companies
Missouri
$2.32K +$2.8K +1,000 New
Raymond James Financial
48
Raymond James Financial
Florida
$2.15K +$2.8K +1,000 New
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$1.69K -$2.41K -860 -52%
IA
50
IFP Advisors
Florida
$974 – – –
1
2
3 4

ADVM Hedge Fund Activity: Q2 2025 in Review

58 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q2 2025, worth a combined $30.1M — down 57% from $69.8M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ADVM and 18 opened new positions — a net loss of 11 holders — while 18 trimmed existing stakes and 9 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.15M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.69M sold.

  • 58 institutional investors held Adverum Biotechnologies (ADVM) as of Q2 2025, down from 70 in Q1 2025.
  • Funds reported $30.1M of Adverum Biotechnologies stock for Q2 2025, down 57% quarter-over-quarter.
  • 18 funds opened new Adverum Biotechnologies positions in Q2 2025 and 29 closed out, a net change of -11 holders.
  • The largest Adverum Biotechnologies buyer in Q2 2025 was Renaissance Technologies, an estimated $1.15M added.
  • The largest Adverum Biotechnologies seller in Q2 2025 was Franklin Resources, an estimated $7.69M sold.

Based on aggregated 13F filings for Q2 2025.